Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 16 Aug 24 424B3 Prospectus supplement
- 26 Mar 24 424B3 Prospectus supplement
- 5 Feb 24 424B3 Prospectus supplement
- 15 Dec 23 424B3 Prospectus supplement
- 26 Sep 23 424B3 Prospectus supplement
- 15 Jun 23 424B4 Prospectus supplement with pricing info
- 14 Jun 23 EFFECT Notice of effectiveness
- 12 Jun 23 S-1/A IPO registration (amended)
- 6 Jun 23 S-1/A IPO registration (amended)
-
31 May 23 S-1/A IPO registration (amended)
- 26 Apr 23 S-1/A IPO registration (amended)
- 15 Feb 23 S-1 IPO registration
COEPW similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Amended Registration Statement on Form S-1/A (No. 333-269782) of our report dated March 28, 2023, relating to the consolidated financial statements of Coeptis Therapeutics Holdings, Inc. (formerly Bull Horn Holdings Corp.) as of December 31, 2022 and 2021, and for each of the two years in the period ended December 31, 2022, which forms part of this Amended Registration Statement.
We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ TURNER, STONE & COMPANY, L.L.P.
Dallas, Texas
May 30, 2023